¿Se asocia la obesidad en la artritis psoriásica a una menor respuesta terapéutica y más efectos adversos con el tratamiento de fondo?

Galíndez, Eva; Carmona, Loreto.
Reumatol. clín. (Barc.) ; 12(6): 307-312, nov.-dic. 2016. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-157430

Documentos relacionados

  1. Management of postinfectious inflammatory arthritis.
  2. Inflammatory arthritis in HIV positive patients: A practical guide.
  3. Association between skin and joint involvement in patients with psoriatic arthritis treated with adalimumab: analysis of data from a German non-interventional study.
  4. Fibroblastic rheumatism: an uncommon arthritis. A case-based review.
  5. Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With Psoriasis.
  6. Bowel-associated dermatosis-arthritis syndrome in a child with very early onset inflammatory bowel disease.
  7. Disseminated Ureaplasma polyarthritis in a renal transplant recipient.
  8. The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients.
  9. Clinical disease activity index applicability in lupus arthropathy: Unraveling underdiagnosed joint activity.
  10. Pityriasis rubra pilaris type IV-associated arthritis treated with adalimumab.